The technology is indicated for use during transforaminal lumbar interbody fusion and is designed to control cage insertion and manipulation during surgery. Testing has shown the device is safe for use and the company is ramping up production of the instrumentation and implants to support increased demand.
Read the release on PIVOTEC.
Related Articles on Spine Devices:
20 Spine Devices Receive FDA 510(k) Clearance in July
NovaBone Introduces New Bone Graft Substitute
Integra LifeSciences Launches Anterior Cervical Fixation System
